Kate Chan Hong Kong

Dr. Kate Chan is a Clinical Associate Professor in the Department of Paediatrics at The Chinese University of Hong Kong. She is also an Honorary Consultant in the Department of Paediatrics, at the Prince of Wales Hospital and the Hong Kong Children’s Hospital. She is a specialist in Paediatric Respiratory and Sleep Medicine. She serves on the Board of Directors of the International Pediatric Sleep Association and is the Honorary Treasurer of the Hong Kong Society of Sleep Medicine. Her research focuses on paediatric sleep-disordered breathing, including its natural history, pathogenesis, diagnostic approaches and interventions, aiming to enhance awareness and advance care for children with sleep-related breathing disorders.
Job Title
Associate Professor
Faculty / Department / Division
Department of Paediatrics, Faculty of Medicine
Institution / Organisation
Chinese University of Hong Kong

19 November 2026, Thursday

Time Session
08:30
13:00
Naricha Chirakalwasan Chairperson Thailand
Rashidah Yasin Chairperson Malaysia
Function Room 8, Ground Mezzanine Floor

21 November 2026, Saturday

Time Session
09:30
10:30
11:00
12:30
Nurhayati Mohd Marzuki Chairperson Malaysia
  • Keiji Fujiwara Presenter Japan
  • Tomonori Sato Presenter Japan
  • Toshitaka Shomura Presenter Japan
    【Background and Aims】 Bendopnea, defined as dyspnea while bending forward, has been primarily studied in heart failure, but its significance in chronic obstructive pulmonary disease (COPD) remains unclear. Airway mucus plugging, quantified by computed tomography (CT), has emerged as an important imaging marker linked to airflow limitation and symptom burden in COPD. We hypothesized that a higher CT-based mucus plug score is independently associated with the presence of bendopnea in COPD patients. 【Methods】 We conducted a retrospective cross-sectional study of 133 patients with COPD. Bendopnea was assessed clinically and was present in 27 patients (20.3%). Mucus plug score was quantified from chest CT images. Patient demographics, pulmonary function tests, low attenuation volume percentage (LAV%), hemodynamic parameters (BNP, TRPG, EF), and symptom scores were compared between groups. Multivariate logistic regression analyses were performed to evaluate the independent association of mucus plug score with bendopnea, adjusting for %FEV1 and LAV%. 【Results】 Bendopnea-positive group exhibited significantly higher mucus plug scores compared to the Bendopnea-negative group (median 2.0 [IQR 1.0–4.0] vs. 0.0 [0.0–1.0], p < 0.001). The Bendopnea-positive group also demonstrated more severe airflow limitation (%FEV1: 51.3% vs. 73.7%, p < 0.001), greater emphysema (LAV%: 12.2% vs. 3.6%, p = 0.008). In contrast, hemodynamic parameters showed no significant between-group differences. In multivariate logistic regression analyses, mucus plug score remained a significant independent predictor of bendopnea across all models: adjusted for %FEV1, adjusted for LAV%, adjusted for both %FEV1 and LAV%. Bendopnea prevalence increased with rising mucus plug scores (P for trend < 0.001). 【Conclusions】 CT-based mucus plug score is significantly and independently associated with bendopnea in COPD patients, irrespective of the degree of airflow limitation, emphysema. These findings suggest that bendopnea may be a clinical clue to mucus-predominant airway disease in COPD.
  • Shih-Yu Chen Presenter Taiwan
    Background The prognostic value of body mass index (BMI) in chronic obstructive pulmonary disease (COPD) remains inconsistent. The clinical implications of phenotyping based on adiposity and muscularity have not been well established. Methods In this prospective multicenter cohort study, patients with spirometry-confirmed COPD (October 2021–December 2023) underwent bioelectrical impedance analysis. Low fat-free mass index (FFMI) was defined as <17.4 kg/m² (men) and <15.0 kg/m² (women); high fat mass index (FMI) as ≥5.9 kg/m² (men) and ≥7.0 kg/m² (women). Participants were classified into four phenotypes: lean-robust (low FMI, high FFMI), wasting (low FMI, low FFMI), sarcopenic obesity (high FMI, low FFMI), and obese-robust (high FMI, high FFMI). The primary outcome was severe acute exacerbation; the secondary outcome was three-year all-cause mortality. Cox proportional hazards models were applied. Results Among 648 participants (mean age 73.2 years; 88.6% male), 6.9% were underweight, 29.9% overweight and 4.9% obese by BMI. Compared with normal weight, underweight was associated with higher risk of severe exacerbation (HR 2.05, 95% CI: 1.27–3.32) and mortality (HR 2.94, 95% CI: 1.50–5.77), whereas overweight showed lower mortality risk (HR 0.24, 95% CI 0.09–0.61). Based on adiposity–muscularity phenotyping, 21.9% were lean-robust, 28.4% wasting, 20.1% sarcopenic obesity, and 29.6% obese-robust. Using lean-robust as reference, wasting and sarcopenic obesity were associated with increased risks of severe exacerbation (HR 1.96, 95% CI:1.26-3.06; HR 1.81, 95% CI:1.12-2.94) and mortality (HR 12.6, 95% CI: 3.01-53.2; HR 15.2, 95% CI: 3.57-64.61). The obese-robust demonstrated comparable risks of severe exacerbation and mortality to the lean-robust group. Conclusion BMI alone inadequately stratifies prognosis in COPD. Phenotyping based on adiposity and muscularity identifies high-risk subgroups more precisely. The apparent obesity paradox may reflect preserved muscularity rather than adiposity itself, underscoring the importance of body composition assessment in clinical practice.
  • Ming Yang Presenter Hong Kong
    Background: Paediatric obstructive sleep apnoea (OSA) is a prevalent disorder characterised by recurrent upper airway obstruction, resulting in hypoxia and sleep fragmentation. Epidemiological evidence links Interleukin (IL)-17A to OSA. However, few studies have examined both local and systemic IL 17A profiles to identify meaningful inflammatory phenotypes, and the relationship between these phenotypes and polysomnographic indices remains unclear. Methods: Children aged 5-12 years underwent clinical assessment and polysomnography. Plasma and nasal epithelial lining fluid (NELF) IL-17A were measured by cytometric bead array, with K-means clustering of standardised values identifying inflammatory phenotypes. Across clusters, differences in obstructive apnoea-hypopnoea index (OAHI), oxygen desaturation index (ODI), and arousal index (ARI) were evaluated using Kruskal-Wallis tests with Dunn's post-hoc tests and confounder-adjusted generalised linear models (GLMs). Results: One hundred and six children were recruited, with plasma and NELF collected. Three distinct IL-17A inflammatory phenotypes were identified as high-IL-17A (n=59), low-IL-17A (n=22), and discordant-IL-17A profiles (n=25) (Figure 1). OAHI (p=0.014) and ARI (p=0.002) differed significantly across clusters, whereas ODI (p=0.837) showed no significant differences. Post-hoc test showed significantly higher OAHI (median (Q1-Q3): 3.23 (0.60-17.12) vs. 0.63 (0.22-2.06), adjusted p=0.022) and ARI (13.70 (9.21-25.63) vs. 8.79 (7.15-10.76), adjusted p=0.003) in the high-IL-17A cluster than those in the low-IL-17A cluster. GLMs showed that both low IL 17A and discordant-IL-17A clusters had significantly lower OAHI than the high IL 17A cluster (low: β=-0.692, 95%CI(-1.280,-0.105), p=0.023; discordant: β=-0.664, 95%CI(-1.223,-0.104), p=0.022), with the same pattern for ARI (low: β=-0.338, 95%CI(-0.604,-0.071), p=0.015; discordant: β=-0.294, 95%CI(-0.548,-0.041), p=0.025), while no significant differences for ODI. Conclusions: Clustering IL-17A from plasma and NELF revealed a distinct inflammatory phenotype with more respiratory events and fragmented sleep. These findings support IL-17A as a biomarker for identifying children with a distinct pattern of specific OSA-related features.
  • Scott J. Denstaedt Presenter United States
  • Rachel Kohn Presenter United States
Function Room 8, Ground Mezzanine Floor
12:30
16:30
19:00
22:00

22 November 2026, Sunday

Time Session
09:00
10:30
Rus Anida Awang Chairperson Malaysia
  • Kate Chan Speaker Hong Kong
  • Naricha Chirakalwasan Speaker Thailand
  • Albert M. Li Speaker Hong Kong
    Childhood obstructive sleep apnoea (OSA) is a common condition linked to a range of complications, including neurocognitive and behavioural impairments, reduced quality of life, and elevated metabolic and cardiovascular risks. Adenotonsillectomy (AT) remains the first-line treatment, offering proven benefits across these domains. Timely diagnosis is therefore essential for early intervention and improved outcomes. Polysomnography (PSG) is the gold standard for diagnosing OSA. However, limited access leads to longer waiting periods. Moreover, the requirement for an overnight hospital stay can be particularly challenging for children. Given current limitations, there is a pressing need for a validated, user-friendly diagnostic tool to enable early and accurate identification of paediatric OSA. Recent research has shifted focus toward nocturnal hypoxaemia. A novel metric, the hypoxic burden (HB), first introduced by Azarbarzin et al., has shown superior predictive value for cardiovascular mortality than the apnoea-hypopnoea index (AHI) in adults. Despite its promise, HB has been criticised for its computational complexity. A more streamlined and accurate alternative, the oxygen desaturation burden index (OBI), has since emerged. This severity metric accounts for both the depth and duration of oxygen desaturations without requiring respiratory event scoring. Importantly, OBI can be derived from simple overnight oximetry, making it a more accessible and cost-effective option for home-based assessments. In this presentation, the speaker will discuss the usefulness of OBI and his research on using this parameter in interventional studies and in assessing cardiovascular complications in children with OSA.
  • Dg Zuraini Sahadan Speaker Malaysia
    From Lab to Wrist: The Emerging Role of Wearables in Paediatric Sleep Medicine Overnight in-laboratory polysomnography (PSG) has long been the gold standard for diagnosing paediatric sleep-disordered breathing. However, long waiting lists, high costs, and the distress of overnight hospital stays for young children have limited patient access. Recent landmark validation studies highlight that specialized paediatric-trained deep learning algorithms—specifically dual-stream local-global Long Short-Term Memory (LSTM) networks which can process raw wrist movement and heart rate signals to achieve 95% ROC-AUC accuracy in classifying sleep and wakefulness. Unlike traditional adult models or older mathematical scoring methods, these paediatric AI classifiers eliminate proportional bias and estimate total sleep duration within minutes of laboratory gold standards. Furthermore, systematic evidence across 62 portable sleep monitoring trials reveals that multi-channel home polygraphy and AI-assisted pulse oximetry offer specificities up to 100% for ruling in severe paediatric Obstructive Sleep Apnea (OSA). This allows clinicians to fast-track children with adenotonsillar hypertrophy for urgent surgical adenotonsillectomy without unnecessary laboratory delays. By combining wrist movement sensors with optical heart rate tracking and paediatric deep learning, we can evaluate children over multiple nights in their natural home environment. This transition from lab to wrist bridges the gap between cutting-edge technology and accessible child healthcare.
  • Q&A
Ballroom 2, Lower Ground Floor